瘤免疫微环境差异与胰腺癌的种族差异相关的差异
Zachary Gao1, Joseph Azar2, Derek Erstad3
1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
The Journal of surgical research
|February 19, 2025
概括
非洲裔美国人和欧洲裔美国胰腺癌患者表现出明显的分子差异,包括TP53突变和免疫基因表达. 这些差异可能解释胰腺腺癌 (PDAC) 的存活率差异.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 在各种癌症中观察到抗瘤免疫的种族差异,可能会影响生存率.
- 在种族群体之间胰腺腺癌 (PDAC) 的分子差异上存在有限的研究.
- 非洲裔美国人 (AA) 和欧洲裔美国人 (EA) PDAC患者可能会经历不同的生物学机制,导致生存差距.
研究的目的:
- 为了研究AA和EA PDAC患者之间的分子和生物差异.
- 确定胰腺癌存活率种族差异的潜在驱动因素.
- 为了探索基因突变和基于种族的免疫基因表达变异.
主要方法:
- 对基因组PDAC突变数据的分析,按种族分层.
- 在手术PDAC标本上进行组织微阵列和多重基因表达分析 (NanoString).
- 在AA和EA队列之间比较TP53突变和免疫基因注释.
主要成果:
- 与EA患者相比,AA PDAC患者的TP53突变率显著更高 (分析了4679个样本).
- 在AA和EA组之间发现了免疫基因注释的显著差异 (P <0.05).
- 组织微阵列包括12个AA和41个EA未经治疗的PDAC样本.
结论:
- 在AA和EA PDAC患者之间存在分子和微环境的区别.
- 这些已识别的差异可能有助于在胰腺癌中观察到的种族生存差异.
- 了解这些分子变异对于改善AA PDAC患者的治疗结果至关重要.
更多相关视频
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
12.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
574
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463